Showcase your Neuroimmune Breakthroughs

This dedicated poster session offers a rare opportunity to showcase your latest breakthroughs in neuroinflammation, neuroimmunology, and CNS-targeted drug development to an audience of senior biopharma innovators and academic opinion leaders. Share your work in a highly collaborative setting, spark scientific dialogue, and build meaningful connections with peers shaping the next generation of neuroimmune therapies. 

Applications are now open for this year's poster session. This is an exclusive opportunity to share what you are currently working on, allowing you to:

  • Demonstrate your thought leadership in this dynamic field
  • Gain visibility and exposure in showcasing your innovations
  • Engage in meaningful discussions with industry peers to receive direct feedback
  • Attract the attention of industry stakeholders and collaborators
Viewing poster
poster session socialising
Explaining poster

How to Submit Your Poster

  • You must first register your place to attend the  8th Neuroimmunology Drug Development Summit 
  • Submit an abstract for review to showcase your poster during the Scientific Poster Session 
  • You will be notified once your abstract has been accepted along with details of printing and size requirements. We do request an online PDF of the poster 2 weeks prior to the summit  
  • Scientific Poster Session: April 15th, 2026 

Please note, there is no additional charge, but you must be attending the conference to submit an abstract. Posters should not be used for sales and marketing purposes. All abstracts are subject to approval by the conference organizers, who reserve the right to reject submissions.

Submit Your Poster

Explore the Full Event Guide

  • 80+ discovery, preclinical & translational neuroimmunology experts from leading biopharma and academia 
  • 3 days of cutting-edge insights across neuroinflammatory targets, glial biology, biomarkers & translational innovation 
  • Deep-dive agenda strand: Bridging Peripheral & Central Immunity, exploring next-generation B & T cell targets enabling earlier, more precise CNS intervention 
  • Hear from 25+ top speakers from Sanofi, Biogen, Merck, AbbVie, BMS, Lundbeck, Vigil Neuroscience and more 
  • Unmissable debates on humanized models, emerging insights into inflammation-driven psychosis mechanisms, and early clinical signals from novel neuroimmune-targeting therapies  
Download the Agenda
Brochure image - NIDD